Search

everythinglearnresearchcommunity

for

Search:↓

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Adalimumab can cause complete hair loss in rare cases.

5-Aminosalicylic acid enemas may cause immediate hair root damage and hair loss.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Aftimoon (Cuscuta reflexa) has various health benefits, including anti-inflammatory and anticonvulsant effects.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Aftimoon has potential health benefits for various diseases and could be integrated into modern healthcare.

Avacopan may cause unexpected side effects, so early monitoring is important.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Clofazimine may be effective for treating ashy dermatosis.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Accurate fungal identification is crucial for proper treatment in immunocompromised patients.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Alefacept does not effectively treat severe alopecia areata.